Business
Cytokinetics and the American Heart Association Bay Area Announce a Three-Year Collaboration to Advance Education and Awareness of Heart Disease
SOUTH SAN FRANCISCO, Calif. and OAKLAND, Calif., Feb. 16, 2022 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) and the American Heart
About this update from Cytokinetics, Incorporated
[{"type":"text","content":"SOUTH SAN FRANCISCO, Calif. and OAKLAND, Calif., Feb. 16, 2022 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) and the American Heart Association (AHA) Bay Area today announced a three-year collaboration to accelerate education and awareness of heart disease. Within the collaboration, Cytokinetics will provide funding and support for several initiatives led by AHA Bay Area. In 2022, Cytokinetics will sponsor the Research Roundtable, a life-sciences industry fundraising event. Cytokinetics will also support several Bay Area Heart Walks by establishing an enhanced VIP area for patients and caregivers, which will provide additional space for friends, families, coworkers and neighbors to demonstrate their commitment to their health and to honor loved ones with heart disease or stroke. Additionally, Cytokinetics will elevate patient voices throughout the year by supporting the development of three new patient videos in the AHA series, “Conversations from the Heart,” to be shared online and on social media. “Partnering with the AHA Bay Area helps us fulfill our responsibility of supporting those in our community, and there’s no better time to announce this collaboration than during Heart Month,” said Robert I. Blum, President and Chief Executive Officer of Cytokinetics. “Heart disease is the leading cause of death in the U.S., and for many diseases such as heart failure, the prevalence is only increasing. As we remain dedicated to our mission to address unmet needs in diseases like heart failure and hypertrophic cardiomyopathy, it remains a top priority to elevate attention of heart disease, and we look forward to continuing to work together with the AHA Bay Area to advance their goals and initiatives.” “We are grateful to be expanding our efforts with Cytokinetics through this collaborative effort,” said Laura Steinfeldt, Senior Vice President and Executive Director of the AHA Bay Area. “Heart disease affects so many people across the country, and Cytokinetics’ support allows us to expand our outreach to patients and caregivers impacted by heart disease in our local communities and ensure equitable access to resources for all.” About Heart Disease Heart disease refers to several types of heart conditions, including coronary artery disease, stroke, heart failure and others. Heart disease is the leading cause of death for...